Top Advances in Cardiology in 2023 скачать в хорошем качестве

Top Advances in Cardiology in 2023

Discover 2023's Pioneering Advances in Peripheral Vascular Disease with Dr. Anuj Shah at Apex Heart & Vascular" Join Dr. Anuj Shah, the Director of Apex Heart and Vascular, in a detailed exploration of the groundbreaking developments in Cardiology treatments and therapies in 2023. In this video, Dr. Shah shares expert insights into the significant strides made in the field, particularly highlighting key randomized control trials that have shaped our current approaches. In 2023, interventional cardiology has seen transformative advancements. Key highlights include the preference for radial angioplasty, the innovative use of intracoronary lithotripsy, and the introduction of drug-coated balloons for coronary applications. Advancements in imaging technologies like IVUS and OCT have improved intervention precision. Significant strides in medical therapy include new treatments for heart failure and hyperlipidemia, with groundbreaking drugs like Entresto and inclisiran leading the way. These developments represent a major leap forward in cardiac care, integrating new techniques and therapies. Heart Failure Treatments Introduction of new blockbuster drugs for both heart failure with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). Notable drugs include Entresto (Neprilysin inhibitor combined with ARB) and Verquvo.) Hyperlipidemia Management New medications like inclisiran (small RNA inhibitor) and bempedoic acid (nexletol) for LDL reduction. Radial Over Femoral Access Transradial access compared with transfemoral access was associated with lower mortality in patients with coronary artery disease undergoing angioplasty. Findings: across multicenter randomized clinical trials and whether these associations are modified by patient or procedural characteristics. Emphasis on using a combination of beta blockers, mineralocorticoid receptor agents, and new heart failure medications for comprehensive management. In hyperlipidemia, a tailored approach with a combination of statins, ezetimibe, PCSK9 inhibitors, inclisiran, and bempedoic acid to optimize LDL management. Lithotripsy Intracoronary Lithotripsy ballooning is negating the need of using complex CSI. Simple to use. Some patients may still need Rotary Atherectomy. Drug Coated Balloons Advantages from Drug Coated Stents without leaving anything behind in the coronary arteries. First trials in the U.S. Imaging-Guided Coronary Interventions Use of IVUS (Intravascular Ultrasound), OCT (Optimum Coherence Tomography), IFR (Instantaneous Wave-Free Ratio), FFR (Fractional Flow Reserve), and Infrared Spectroscopy. Enhanced plaque morphology assessment and physiological lesion analysis.